Phase I trial investigating the tolerability, pharmacodynamics and pharmacokinetics of escalating single doses of S-mecamylamine in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2008
At a glance
- Drugs Dexmecamylamine (Primary)
- Indications Depressive disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Targacept
- 18 Mar 2008 Status change from planning to recruiting, as reported by a Targacapt media release.
- 01 Nov 2007 New trial record.